Live Breaking News & Updates on Myrisk hereditary cancer test

Stay informed with the latest breaking news from Myrisk hereditary cancer test on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Myrisk hereditary cancer test and stay connected to the pulse of your community

Myriad Genetics, Inc. (NASDAQ:MYGN) Given Consensus Rating of "Hold" by Brokerages

Myriad Genetics, Inc. (NASDAQ:MYGN) Given Consensus Rating of "Hold" by Brokerages
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United-states , Wellington , New-zealand-general- , New-zealand , Nasdaq , Genetics-inc , Wellington-management-group , Virtu-financial , Vanguard-group-inc , Fisher-asset-management , Allspring-global-investments-holdings

Myriad Genetics, Inc. (NASDAQ:MYGN) Given Average Rating of "Hold" by Brokerages

Shares of Myriad Genetics, Inc. (NASDAQ:MYGN – Get Free Report) have received an average recommendation of “Hold” from the six analysts that are presently covering the stock, Marketbeat.com reports. One analyst has rated the stock with a sell recommendation, two have assigned a hold recommendation and three have assigned a buy recommendation to the company. […]

United-states , Wellington , New-zealand-general- , New-zealand , Sei-investments-co , Wellington-management-group , Genetics-company-profile , Genetics-inc , Nasdaq , Earnest-partners , Goldman-sachs-group

Brokerages Set Myriad Genetics, Inc. (NASDAQ:MYGN) Price Target at $23.17

Shares of Myriad Genetics, Inc. (NASDAQ:MYGN – Get Free Report) have been given an average rating of “Hold” by the six brokerages that are covering the firm, MarketBeat reports. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and three have given a buy rating to […]

Canada , Hong-kong , China , United-states , Nasdaq , Tower-research-capital , Goldman-sachs-group , Genetics-company-profile , Hong-kong-ltd , Royal-bank , China-universal-asset-management-co

Myriad Genetics, Inc. (NASDAQ:MYGN) Shares Bought by China Universal Asset Management Co. Ltd.

China Universal Asset Management Co. Ltd. raised its holdings in Myriad Genetics, Inc. (NASDAQ:MYGN – Free Report) by 388.0% during the fourth quarter, HoldingsChannel.com reports. The firm owned 10,253 shares of the company’s stock after buying an additional 8,152 shares during the period. China Universal Asset Management Co. Ltd.’s holdings in Myriad Genetics were worth […]

Wellington , New-zealand-general- , New-zealand , China , United-states , Piper-sandler , Deutsche-bank , Jump-financial , Invesco-ltd , Genetics-inc , Qube-research-technologies-ltd , China-universal-asset-management-co

Myriad Genetics (NASDAQ:MYGN) Releases Earnings Results, Beats Expectations By $0.03 EPS

Myriad Genetics (NASDAQ:MYGN – Get Free Report) issued its quarterly earnings results on Tuesday. The company reported $0.04 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.01 by $0.03, Briefing.com reports. The business had revenue of $196.60 million for the quarter, compared to analysts’ expectations of $194.80 million. Myriad Genetics had […]

Canada , Hong-kong , United-states , Piper-sandler , Wolfe-research , Tower-research-capital , Wells-fargo-company , Us-bancorp , Jpmorgan-chase-co , Royal-bank , Goldman-sachs-group , Genetics-company-profile

Myriad Genetics (NASDAQ:MYGN) Releases FY 2024 Earnings Guidance

Myriad Genetics (NASDAQ:MYGN – Get Free Report) issued an update on its FY 2024 earnings guidance on Tuesday morning. The company provided earnings per share (EPS) guidance of 0.000-0.050 for the period, compared to the consensus estimate of -0.010. The company issued revenue guidance of $820.0 million-$840.0 million, compared to the consensus revenue estimate of […]

Wellington , New-zealand-general- , New-zealand , United-states , America , Piper-sandler , America-corp , Goldman-sachs-group , Wellington-management-group , Vanguard-group-inc , Wells-fargo-company , Wolfe-research

Profund Advisors LLC Sells 1,086 Shares of Myriad Genetics, Inc. (NASDAQ:MYGN)

Profund Advisors LLC decreased its holdings in shares of Myriad Genetics, Inc. (NASDAQ:MYGN – Free Report) by 2.7% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 38,839 shares of the company’s stock after selling 1,086 shares during the period. Profund Advisors LLC’s […]

United-states , Piper-sandler , Jump-financial , Profund-advisors , Charles-schwab-investment-management-inc , Nasdaq , Jpmorgan-chase-co , Genetics-inc , Exchange-commission , Wolfe-research , Goldman-sachs-group , Fund-management-co

Myriad Genetics (NASDAQ:MYGN) Issues FY24 Earnings Guidance

Myriad Genetics (NASDAQ:MYGN) Issues FY24 Earnings Guidance
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United-states , Canada , Piper-sandler , Cresset-asset-management , Wells-fargo-company , Royal-bank , Goldman-sachs-group , Ameritas-investment-partners-inc , Pricet-rowe-associates-inc , Us-bancorp , Genetics-inc , Genetics-company-profile

Myriad Genetics (NASDAQ:MYGN) Updates FY24 Earnings Guidance

Myriad Genetics (NASDAQ:MYGN) Updates FY24 Earnings Guidance
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United-states , Piper-sandler , Wells-fargo-company , Vanguard-group-inc , Group-plc , Wolfe-research , Goldman-sachs-group , Pricet-rowe-associates-inc , Genetics-inc , Barclays-plc , Genetics-company-profile , Voloridge-investment-management

Myriad Genetics (MYGN) to Release Quarterly Earnings on Tuesday

Myriad Genetics (MYGN) to Release Quarterly Earnings on Tuesday
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United-states , Piper-sandler , Barclays-plc , Vanguard-group-inc , Nasdaq , Wells-fargo-company , Voloridge-investment-management , Goldman-sachs-group , Genetics-company-profile , Jpmorgan-chase-co , Pricet-rowe-associates-inc , Genetics-inc